Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
Market Closed -
Other stock markets
|
Pre-market 12:37:29 | |||
166.6 USD | +1.59% | 164.5 | -1.24% |
05-27 | US, European nations consider vaccinating workers exposed to bird flu | RE |
05-24 | Novavax awaits FDA decision on whether its next COVID shot can be offered in US | RE |
Sept 26 (Reuters) - EMA:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+43.00% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B | |
-8.12% | 11.19B |